345 related articles for article (PubMed ID: 34777333)
21. The dynamics of immune response in COVID-19 patients with different illness severity.
Zhang B; Yue D; Wang Y; Wang F; Wu S; Hou H
J Med Virol; 2021 Feb; 93(2):1070-1077. PubMed ID: 32910461
[TBL] [Abstract][Full Text] [Related]
22. Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients.
Guo Y; Li T; Xia X; Su B; Li H; Feng Y; Han J; Wang X; Jia L; Bao Z; Li J; Liu Y; Li L
Front Immunol; 2021; 12():723585. PubMed ID: 34489974
[TBL] [Abstract][Full Text] [Related]
23. Interrogation of the cellular immunome of cancer patients with regard to the COVID-19 pandemic.
Donahue RN; Marté JL; Goswami M; Toney NJ; Tsai YT; Gulley JL; Schlom J
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707314
[TBL] [Abstract][Full Text] [Related]
24. T Cell Activation, Highly Armed Cytotoxic Cells and a Shift in Monocytes CD300 Receptors Expression Is Characteristic of Patients With Severe COVID-19.
Zenarruzabeitia O; Astarloa-Pando G; Terrén I; Orrantia A; Pérez-Garay R; Seijas-Betolaza I; Nieto-Arana J; Imaz-Ayo N; Pérez-Fernández S; Arana-Arri E; Borrego F
Front Immunol; 2021; 12():655934. PubMed ID: 33777054
[TBL] [Abstract][Full Text] [Related]
25. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.
Christensen EE; Jørgensen MJ; Nore KG; Dahl TB; Yang K; Ranheim T; Huse C; Lind A; Nur S; Stiksrud B; Jenum S; Tonby K; Holter JC; Holten AR; Halvorsen B; Dyrhol-Riise AM
J Intern Med; 2021 Sep; 290(3):677-692. PubMed ID: 34080738
[TBL] [Abstract][Full Text] [Related]
26. NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19.
Bergantini L; d'Alessandro M; Cameli P; Cavallaro D; Gangi S; Cekorja B; Sestini P; Bargagli E
Cells; 2021 Nov; 10(11):. PubMed ID: 34831404
[TBL] [Abstract][Full Text] [Related]
27. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
[TBL] [Abstract][Full Text] [Related]
28. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.
Koutsakos M; Rowntree LC; Hensen L; Chua BY; van de Sandt CE; Habel JR; Zhang W; Jia X; Kedzierski L; Ashhurst TM; Putri GH; Marsh-Wakefield F; Read MN; Edwards DN; Clemens EB; Wong CY; Mordant FL; Juno JA; Amanat F; Audsley J; Holmes NE; Gordon CL; Smibert OC; Trubiano JA; Hughes CM; Catton M; Denholm JT; Tong SYC; Doolan DL; Kotsimbos TC; Jackson DC; Krammer F; Godfrey DI; Chung AW; King NJC; Lewin SR; Wheatley AK; Kent SJ; Subbarao K; McMahon J; Thevarajan I; Nguyen THO; Cheng AC; Kedzierska K
Cell Rep Med; 2021 Mar; 2(3):100208. PubMed ID: 33564749
[TBL] [Abstract][Full Text] [Related]
29. Impaired Cellular Immunity to SARS-CoV-2 in Severe COVID-19 Patients.
Ni L; Cheng ML; Feng Y; Zhao H; Liu J; Ye F; Ye Q; Zhu G; Li X; Wang P; Shao J; Deng YQ; Wei P; Chen F; Qin CF; Wang G; Li F; Zeng H; Dong C
Front Immunol; 2021; 12():603563. PubMed ID: 33603759
[TBL] [Abstract][Full Text] [Related]
30. Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes.
Lombardi A; Trombetta E; Cattaneo A; Castelli V; Palomba E; Tirone M; Mangioni D; Lamorte G; Manunta M; Prati D; Ceriotti F; Gualtierotti R; Costantino G; Aliberti S; Scaravilli V; Grasselli G; Gori A; Porretti L; Bandera A
Front Immunol; 2020; 11():560330. PubMed ID: 33362757
[TBL] [Abstract][Full Text] [Related]
31. Severe COVID-19 Recovery Is Associated with Timely Acquisition of a Myeloid Cell Immune-Regulatory Phenotype.
Trombetta AC; Farias GB; Gomes AMC; Godinho-Santos A; Rosmaninho P; Conceição CM; Laia J; Santos DF; Almeida ARM; Mota C; Gomes A; Serrano M; Veldhoen M; Sousa AE; Fernandes SM
Front Immunol; 2021; 12():691725. PubMed ID: 34248984
[TBL] [Abstract][Full Text] [Related]
32. Immune characterization of a Colombian family cluster with SARS-CoV-2 infection.
Aguilar-Jiménez W; Flórez-Álvarez L; Rincón DS; Marín-Palma D; Sánchez-Martínez A; Martínez J; Zapata MI; Loaiza JD; Cárdenas C; Guzmán F; Velilla PA; Taborda NA; Zapata W; Hernández JC; Díaz FJ; Rugeles MT
Biomedica; 2021 Oct; 41(Sp. 2):86-102. PubMed ID: 34669281
[TBL] [Abstract][Full Text] [Related]
33. Sex-based clinical and immunological differences in COVID-19.
Huang B; Cai Y; Li N; Li K; Wang Z; Li L; Wu L; Zhu M; Li J; Wang Z; Wu M; Li W; Wu W; Zhang L; Xia X; Wang S; Chen H; Wang Q
BMC Infect Dis; 2021 Jul; 21(1):647. PubMed ID: 34225644
[TBL] [Abstract][Full Text] [Related]
34. Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome?
Sami R; Fathi F; Eskandari N; Ahmadi M; ArefNezhad R; Motedayyen H
Cytokine; 2021 Apr; 140():155439. PubMed ID: 33524886
[TBL] [Abstract][Full Text] [Related]
35. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
Front Immunol; 2021; 12():684014. PubMed ID: 34194438
[TBL] [Abstract][Full Text] [Related]
36. Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients.
Marcos-Jiménez A; Sánchez-Alonso S; Alcaraz-Serna A; Esparcia L; López-Sanz C; Sampedro-Núñez M; Mateu-Albero T; Sánchez-Cerrillo I; Martínez-Fleta P; Gabrie L; Del Campo Guerola L; Rodríguez-Frade JM; Casasnovas JM; Reyburn HT; Valés-Gómez M; López-Trascasa M; Martín-Gayo E; Calzada MJ; Castañeda S; de la Fuente H; González-Álvaro I; Sánchez-Madrid F; Muñoz-Calleja C; Alfranca A
Eur J Immunol; 2021 Mar; 51(3):634-647. PubMed ID: 33251605
[TBL] [Abstract][Full Text] [Related]
37. Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?
Vitelli-Avelar DM; Sathler-Avelar R; Massara RL; Borges JD; Lage PS; Lana M; Teixeira-Carvalho A; Dias JC; Elói-Santos SM; Martins-Filho OA
Clin Exp Immunol; 2006 Jul; 145(1):81-92. PubMed ID: 16792677
[TBL] [Abstract][Full Text] [Related]
38. TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C.
Hoste L; Roels L; Naesens L; Bosteels V; Vanhee S; Dupont S; Bosteels C; Browaeys R; Vandamme N; Verstaen K; Roels J; Van Damme KFA; Maes B; De Leeuw E; Declercq J; Aegerter H; Seys L; Smole U; De Prijck S; Vanheerswynghels M; Claes K; Debacker V; Van Isterdael G; Backers L; Claes KBM; Bastard P; Jouanguy E; Zhang SY; Mets G; Dehoorne J; Vandekerckhove K; Schelstraete P; Willems J; ; Stordeur P; Janssens S; Beyaert R; Saeys Y; Casanova JL; Lambrecht BN; Haerynck F; Tavernier SJ
J Exp Med; 2022 Feb; 219(2):. PubMed ID: 34914824
[TBL] [Abstract][Full Text] [Related]
39. Immunological imprint of COVID-19 on human peripheral blood leukocyte populations.
Kratzer B; Trapin D; Ettel P; Körmöczi U; Rottal A; Tuppy F; Feichter M; Gattinger P; Borochova K; Dorofeeva Y; Tulaeva I; Weber M; Grabmeier-Pfistershammer K; Tauber PA; Gerdov M; Mühl B; Perkmann T; Fae I; Wenda S; Führer H; Henning R; Valenta R; Pickl WF
Allergy; 2021 Mar; 76(3):751-765. PubMed ID: 33128792
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths.
Xiong L; Zang X; Feng G; Zhao F; Wang S; Zeng W; Yu K; Zhai Y
Aging (Albany NY); 2021 Mar; 13(5):6289-6297. PubMed ID: 33711813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
